DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans cut its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 36.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 193,302 shares of the medical instruments supplier's stock after selling 109,095 shares during the period. Thrivent Financial for Lutherans owned approximately 0.10% of DENTSPLY SIRONA worth $3,669,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Nordea Investment Management AB grew its stake in shares of DENTSPLY SIRONA by 245.0% during the 4th quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier's stock valued at $4,754,000 after buying an additional 178,639 shares during the period. JPMorgan Chase & Co. grew its stake in DENTSPLY SIRONA by 206.3% during the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after buying an additional 1,244,326 shares during the period. Bank of New York Mellon Corp increased its holdings in DENTSPLY SIRONA by 27.9% in the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock valued at $45,611,000 after purchasing an additional 523,692 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in DENTSPLY SIRONA by 1.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock valued at $39,880,000 after purchasing an additional 35,360 shares during the period. Finally, Barclays PLC lifted its stake in shares of DENTSPLY SIRONA by 21.8% during the third quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock worth $8,301,000 after purchasing an additional 54,920 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several brokerages recently commented on XRAY. Robert W. Baird dropped their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a report on Friday, February 28th. StockNews.com lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Morgan Stanley cut their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating on the stock in a report on Tuesday, December 17th. Jefferies Financial Group lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating and dropped their target price for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. Finally, Evercore ISI reissued an "in-line" rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Twelve research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $23.33.

Insider Buying and Selling

In related news, Director Gregory T. Lucier bought 15,142 shares of the stock in a transaction dated Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the acquisition, the director now owns 81,971 shares of the company's stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.52% of the stock is owned by company insiders.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock traded down $0.71 during mid-day trading on Friday, reaching $14.93. The company's stock had a trading volume of 2,436,694 shares, compared to its average volume of 3,093,060. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a twelve month low of $14.78 and a twelve month high of $33.22. The business has a 50 day moving average price of $17.62 and a 200-day moving average price of $20.16. The firm has a market cap of $2.97 billion, a price-to-earnings ratio of -7.21, a PEG ratio of 1.80 and a beta of 0.98.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.29%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio is presently -14.07%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.